Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lan Fan

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Evidence-Based Complementary and Alternative Medicine : Ecam|June 6, 2013
The rs1142345 in TPMT Affects the Therapeutic Effect of Traditional Hypoglycemic Herbs in PrediabetesXi Li, Feng-Mei Lian, Dong Guo, et al.
Nature Methods|July 10, 2023
A positively tuned voltage indicator for extended electrical recordings in the brainS Wenceslao Evans, Dong-Qing Shi, Mariya Chavarha, et al.
Human Vaccines & Immunotherapeutics|May 16, 2025
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trialXiao-Qiang Liu, Yang-Yang Qi, Tao Huang, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Evidence-Based Complementary and Alternative Medicine : Ecam|June 6, 2013
The rs1142345 in TPMT Affects the Therapeutic Effect of Traditional Hypoglycemic Herbs in PrediabetesXi Li, Feng-Mei Lian, Dong Guo, et al.
Nature Methods|July 10, 2023
A positively tuned voltage indicator for extended electrical recordings in the brainS Wenceslao Evans, Dong-Qing Shi, Mariya Chavarha, et al.
Human Vaccines & Immunotherapeutics|May 16, 2025
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trialXiao-Qiang Liu, Yang-Yang Qi, Tao Huang, et al.
Pageof 14